AbbVie (ABBV) Payout Ratio (2013 - 2026)

AbbVie (ABBV) has reported Payout Ratio for 14 consecutive years, with 0.85 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Payout Ratio fell 72.55% year-over-year to 0.85 in Q2 2026; TTM through Jun 2026 was 1.9, a 36.92% decrease from a year earlier, with the FY2025 full-year figure at 2.75, up 7.06% from the prior year.
• Payout Ratio was 0.85 for Q2 2026 at AbbVie, down from 4.43 in the prior quarter.
• Over five years, Payout Ratio peaked at 15.48 in Q3 2025 and troughed at 119.65 in Q4 2024.
• A 5-year average of 5.71 and a median of 1.68 in 2024 frame the typical range for Payout Ratio.
• Across the five-year window, Payout Ratio tumbled 4979.51% in 2023 and surged 780.3% in 2025, its largest moves.
• Over 5 years, Payout Ratio stood at 1.01 in 2022, then soared by 214.37% to 3.19 in 2023, then sank by 3854.51% to 119.65 in 2024, then soared by 101.34% to 1.6 in 2025, then slumped by 47.06% to 0.85 in 2026.
• The last three Payout Ratio figures came in at 0.85 (Q2 2026), 4.43 (Q1 2026), and 1.6 (Q4 2025), per Business Quant data.